Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer.

Lockhart AC, Cropp GF, Berlin JD, Donnelly E, Schumaker RD, Schaaf LJ, Hande KR, Fleischer AC, Hannah AL, Rothenberg ML
Am J Clin Oncol. 2006 29 (2): 109-15

PMID: 16601426 · DOI:10.1097/

MeSH Terms (18)

Aged Antineoplastic Combined Chemotherapy Protocols Camptothecin Colorectal Neoplasms Drug Administration Schedule Female Fluorouracil Humans Indoles Infusions, Intravenous Injections, Intravenous Irinotecan Leucovorin Male Middle Aged Neoplasm Metastasis Pyrroles Vascular Endothelial Growth Factor Receptor-2

Connections (3)

This publication is referenced by other Labnodes entities: